Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 48 (ZNF48) is a protein likely involved in transcriptional regulation, based on its structural classification as a C2H2-type zinc finger protein and by its inclusion in the largest transcription factor family in humans[5][2]. These proteins typically contain multiple zinc finger motifs that bind to specific regions of DNA and regulate gene expression[1][2][3]. ZNF48, like most family members, primarily functions by binding DNA to either promote or repress transcription, thereby contributing to the regulation of diverse cellular processes such as cell differentiation, proliferation, and patterning[2][4]. There is currently no evidence that ZNF48 is a direct therapeutic target, nor are there drugs or biomarkers specifically linked to this protein. The gene ZNF48 is one of many human zinc finger proteins, and while the family as a whole has been implicated in diseases like cancer and neurodegenerative disorders, there are no disease associations specific to ZNF48 reported in current literature[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 48 (ZNF48).